Stockreport

NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024 [Yahoo! Finance]

NRX Pharmaceuticals, Inc.  (NRXP) 
PDF Jonathan Javitt , Chairman, CEO and Chief Scientist will present at NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference at Florida Atl [Read more]